positive
Recently
OpenAI Invests in Biosecurity Startup Valthos to Strengthen AI-Driven Biodefense
No Image
OpenAI invests $30 million in Valthos, an AI-based biosecurity firm combating engineered biothreats using genomic intelligence and deep-learning surveillance technology.
OpenAI has joined Founders Fund and Lux Capital in a $30 million seed round for Valthos, a biosecurity startup using artificial intelligence to detect and prevent engineered biological threats. The company’s system applies deep genomic modeling to identify anomalies that could indicate lab-created pathogens or bioengineering misuse. Analysts view this move as OpenAI’s first major investment into global biodefense and AI safety, aligning with its broader focus on responsible and safe artificial intelligence applications.